China Pharma Holdings, Inc.
CPHI
$0.82
-$0.02-2.38%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.47M | -3.55M | -3.19M | -3.19M | -3.66M |
| Total Depreciation and Amortization | 3.05M | 2.23M | 1.58M | 1.51M | 1.85M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -13.53M | -13.33M | -13.11M | 522.80K | 464.50K |
| Change in Net Operating Assets | 14.78M | 14.78M | 14.84M | 1.42M | 1.79M |
| Cash from Operations | -173.10K | 134.00K | 115.60K | 262.40K | 452.40K |
| Capital Expenditure | -1.10K | -1.00K | -59.30K | -78.30K | -68.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -45.30K | -45.30K | -45.30K | -293.30K | -253.30K |
| Cash from Investing | -46.40K | -46.30K | -104.60K | -371.70K | -321.90K |
| Total Debt Issued | 130.90K | 961.10K | 961.10K | 260.30K | 1.01M |
| Total Debt Repaid | -284.80K | -1.26M | -1.26M | -536.00K | -1.15M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -154.00K | -296.50K | -294.00K | -275.70K | -146.70K |
| Foreign Exchange rate Adjustments | 53.40K | -35.30K | 1.30K | -66.00K | -98.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -320.10K | -244.20K | -281.80K | -451.10K | -114.30K |